Micoxolamina 1% cream is indicated for the treatment of cutaneous mycoses caused by sensitive fungi.
Composition
MICOXOLAMINA 1% CREAM 100 g of cream contain: active ingredient Ciclopiroxolamina 1 g. MICOXOLAMINA 1% SKIN EMULSION 100 g of skin emulsion contain: active ingredient Ciclopiroxolamina 1 g. MICOXOLAMINA 1% SKIN SOLUTION 100 g of cutaneous solution contain: active ingredient Ciclopiroxolamina 1 g. For excipients, see 6.1
Excipients
CREAM: ethylene glycol and polyoxyethylene glycol palmito-stearic, glycerides of polyoxyethylene saturated fatty acids, petroleum jelly, benzoic acid, butylhydroxyanisole, purified water. SKIN EMULSION: ethylene glycol and polyoxyethylene glycol palmito-stearic, glycerides of polyoxyethylene saturated fatty acids, petroleum jelly, benzoic acid, lactic acid, butylhydroxyanisole, purified water. SKIN SOLUTION: monoethanolamine lauryl sulfate, polyethylene glycol 150 stearate, polysorbate 20, lecithindiethanolamide, sodium edetate, benzyl alcohol, perfume, lactic acid, purified water.
Posology
Apply 2 or 3 times a day, depending on the severity of the pathology, on the lesions and immediately surrounding areas, with a light massage. Repeat the treatment until the lesions disappear (usually 1–2 weeks). To prevent relapses, it is advisable to continue the therapy for a further 1–2 weeks. An occlusive dressing is recommended in the treatment of onychomycosis.
Product images are purely indicative and may differ in graphics, size or content . Even the names of the products, the ingredients and the percentages described are purely indicative and the manufacturing companies could make changes or updates. The only element of identification is the ministerial code MINSAN. Pharmaserena declines all responsibility for any errors, omissions or lack of product updates.